Novozymes AS Profile

USD 0.07  0.13%

Novozymes AS Summary

Novozymes AS (NVZMY) is traded on OTC Market in USA. It is located in Krogshoejvej 36 and employs 6,318 people. The company currently falls under 'Large-Cap' category with current market capitalization of 15.09 B. Novozymes AS has 295.2 M outstanding shares. NOVOZYMES UNSPN A has accumulated about 111.93 M in cash with 584.36 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Check Novozymes AS Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 52.33HorizonTargetOdds Above 52.33
91.32%30 days 52.33 8.47%
Based on normal probability distribution, the odds of Novozymes AS to move above current price in 30 days from now is about 8.47% (This Novozymes AS probability density function shows the probability of Novozymes AS Stock to fall within a particular range of prices over 30 days) .

Novozymes AS Risk Profiles

Key Fundamentals

Novozymes AS Against Markets

Current Ratings

Novozymes AS 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Novozymes AS are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novozymes AS produces and sells industrial enzymes and microorganisms worldwide. Novozymes AS was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes AS is traded on OTC Market in USA. more
NameNovozymes AS
CEO and PresPeder NielsenView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressKrogshoejvej 36
ExchangeOTC Market
Phone45 44 46 00 00
CurrencyUSD - US Dollar

Novozymes AS Corporate Directors

Kasim Kutay Director
Agnete RaaschouNielsen Director
Joergen Rasmussen Independent Director
Please see also Stocks Correlation. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.